The Relative Importance of the Factors II, VII, IX and X for the Prothrombinase Activity in Plasma of Orally Anticoagulated Patients

Abstract

The individual importance of each of the four vitamin Independent clotting factors on the generation of prothrombinase activity in the plasma of orally anticoagulated patients has been investigated.

Addition of purified factors VII, IX or X to plasma from deeply anticoagulated patients (International Normalized Ratio 2.8-4.8) did not influence the amount of prothrombinase activity or the amount of thrombin formed. Only the prothrombin level in the plasma determines the course of thrombin generation. Addition of increasing amounts of purified factor II, VII, IX or X to plasmas deficient in respectively factor II, VII, IX or X showed that the prothrombinase activity increases linearily with the concentration of factor II added and that the concentration below which the factors VII, IX and X start to have a measurable effect on prothrombinase activity are 5%, 20% and 30%, respectively. Half maximal prothrombinase activity was found at about 1% factor VII, 5% factor IX and 8% factor X respectively.

From these observations we conclude that primarily the variation in factor II level determines thrombin generation and hence presumably the antithrombotic effect of oral anticoagulant therapy. It therefore seems likely that, for the control of oral anticoagulant therapy, tests that reflect factor II activity would be suitable.

Keywords

Anticoagulant treatment - Prothrombin - Prothrombinase - Vitamin K antagonists

• References

• 1 Stenflo J, Suttie JW. Vitamin K-dependent formation of γ-carboxyglutamic acid. Ann Rev Biochem 1977; 46: 157-172
• 2 Hemker HC, Veltkamp JJ, Hensen A, Loeliger EA. Nature of prothrombin biosynthesis. Preprothrombinaemia in vitamin K deficiency. Nature. 1963: 589-590
• 3 Reekers PPM, Lindhout MJ, Kop-Klaassen BB M, Hemker HC. Demonstration of three anomalous plasma proteins induced by a vitamin K antagonist. BBA 1973; 317: 559-562
• 4 van Dam-Mieras MCE, Hemker HC. Half-life time and control frequency of vitamin K-dependent coagulation factors. Theoretical considerations on the place of factor VII in the control of oral anticoagulation therapy. Haemostasis 1983; 13: 201-208
• 5 Loeliger EA, van der Esch B, Mattem MJ, den Brabander ASA. Behaviour of factor II, VII, IX and X during long-term treatment with coumarin. Thromb Diath Haemorrh 1963; 9: 74-89
• 6 Loeliger EA. The optimal therapeutic range in oral anticoagulation: History and proposal. Thromb Haemostas 1979; 42: 1141-1152
• 7 van Dam-Mieras MCE, Muller AD, van Dieijen G, Hemker HC. In: Methods of Enzymatic Analysis. Enzymes 3: Peptidases, Proteinases and Their Inhibitors. (; V). Bergmeyer HU. (ed) Verlag Chemie; Weinheim: 1984: 352-394
• 8 Lindhout T, Govers-Riemslag JW P, van de Waart P, Rosing J, Hemker HC. Factor V_a - factor X_a interaction. Effects of phospholipid vesicles of varying composition. Biochemistry 1982; 21: 5494-5502
• 9 Fujikawa K, Legaz ME, Kato H, Davie EW. The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XI _a(activated plasma thromboplastin antecedent). Biochemistry 1974; 13: 4508-4516
• 10 Hemker HC, Willems GN, Beguin S. A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemostas 1986; 56: 9-17
• 11 Loeliger EA, van Dijk-Wierda CA, van den Besselaar AM H P, Broekmans AW, Roos J. Anticoagulant control and the risk of bleeding. In: Anticoagulants and Myocardial Infarction. Meade TW. (ed) John Wiley; Chichester:
• 12 Ma Xi, Beguin S, Hemker HC. The importance of factor IX dependent prothrombinase formation - The Josso Pathway - in clotting plasma. Haemostasis. 1989. accepted
• 13 Hemker HC. Why do hemophiliacs bleed? “In memory of Francois Josso”. Scand J Haematol 1984; 33: 11-19